Immunology of diabetes society T-cell workshop: HLA class I tetramer-directed epitope validation initiative T-cell workshop report-HLA class I tetramer validation initiative

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 720-726

  Mallone, R ^a,b,c   Scotto, M ^a,b,c   Janicki, C N ^d   James, E A ^e   Fitzgerald Miller, L ^f   Wagner, R ^f   Gottlieb, P ^f   Thorpe, J ^e   Jospe, N ^g   Durinovic Bello I ^e   Boitard, C ^a,b,c   Lou, O ^h   Dayan, C M ^d   Wong, F S ^d  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^e BENAROYA RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^h Juvenile Diabetes Research Foundation International   (United States)

Author keywords

Antigen; Autoimmunity; ELISpot; GAD; Insulin

Indexed keywords

GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE[114-122]; GLUTAMATE DECARBOXYLASE[536-545]; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1 PENTAMER; HLA ANTIGEN CLASS 1 TETRAMER; PREPROINSULIN; PREPROINSULIN[A12-20]; PREPROINSULIN[B10-18]; TETRAMER; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES, T-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; INSULIN; INTERFERON-GAMMA; PROTEIN PRECURSORS;

EID: 80855147987     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1243     Document Type: Article

References (25)

1. Nejentsev S, Howson JM, Walker NM, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450(7171): 887-892.
2. Noble JA, Valdes AM, Varney MD, et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010; 59(11): 2972-2979.
3. Wicker LS, Leiter EH, Todd JA, et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994; 43(3): 500-504.
4. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994; 43(3): 505-509.
5. Wong FS, Karttunen J, Dumont C, et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999; 5(9): 1026-1031.
6. Lieberman SM, Evans AM, Han B, et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 2003; 100(14): 8384-8388.
7. Itoh N, Hanafusa T, Miyazaki A, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993; 92(5): 2313-2322.
8. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29(5): 267-274.
9. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155(2): 173-181.
10. Sibley RK, Sutherland DE, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53(2): 132-144.
11. Hassainya Y, Garcia-Pons F, Kratzer R, et al. Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 2005; 54(7): 2053-2059.
12. Pinkse GG, Tysma OH, Bergen CA, et al. Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 2005; 102(51): 18425-18430.
13. Toma A, Haddouk S, Briand JP, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 2005; 102(30): 10581-10586.
14. Skowera A, Ellis RJ, Varela-Calvino R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008; 118(10): 3390-3402.
15. Panina-Bordignon P, Lang R, van Endert PM, et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995; 181(5): 1923-1927.
16. Blancou P, Mallone R, Martinuzzi E, et al. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J Immunol 2007; 178(11): 7458-7466.
17. Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP. Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol 2008; 127(3): 359-365.
18. Panagiotopoulos C, Qin H, Tan R, Verchere CB. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 2003; 52(11): 2647-2651.
19. Mallone R, Martinuzzi E, Blancou P, et al. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 2007; 56(3): 613-621.
20. Martinuzzi E, Novelli G, Scotto M, et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 2008; 57(5): 1312-1320.
21. Velthuis JH, Unger WW, Abreu JRF, et al. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 2010; 59(7): 1721-1730.
22. Mallone R, Mannering SI, Brooks-Worrell BM, et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol 2011; 163(1): 33-49.
23. Oh S, Stegman B, Pendleton CD, et al. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology 2006; 352(2): 390-399.
24. Mannering SI, Wong FS, Durinovic-Bello I, et al. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin Exp Immunol 2010; 162(2): 197-209.
25. Monti P, Scirpoli M, Rigamonti A, et al. Evidence for in vivo primed and ex- panded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol 2007; 179(9): 5785-5792.